Mukund Paravasthu

COO · NovoCure Ltd

Rank #25,295 SEC EDGAR (United States) ↗ Files from United States

Details

Officer of the companyMedical Devices & DiagnosticsNVCRSEC CIK 0002039078

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$1.3M
1-day change
▲ 1.70%
Positions on file
2
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$738.5K – $1.3M2026-09-04

Insider activity Nov 1, 2024 – Mar 5, 2026

Mukund Paravasthu is recorded in filings to the U.S. SEC via EDGAR as officer of the company, and reported 18 transactions between Nov 1, 2024 and Mar 5, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$809.9K
12 sales on file priced rows only
All reported transactions
18
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Mukund Paravasthu sold 43,246 NovoCure Ltd (NVCR) shares for $595,497 on Mar 5, 2026

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Mukund Paravasthu sold 43,246 NovoCure Ltd (NVCR) shares for $595,497 on Mar 5, 2026
Date Insider Transaction Shares Price Value Filing
Mar 5, 2026 Mukund Paravasthu S Open-market sale 43,246 held after: 72,832 $13.77 $595,497 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Mukund Paravasthu sold 43,246 NovoCure Ltd (NVCR) shares for $595,497 on Mar 5, 2026

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

Mukund Paravasthu sold 43,246 NovoCure Ltd (NVCR) shares for $595,497 on Mar 5, 2026
Date Insider Transaction Shares Price Value Filing
Mar 5, 2026 Mukund Paravasthu S Open-market sale 43,246 held after: 72,832 $13.77 $595,497 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Mukund Paravasthu sold 5,377 NovoCure Ltd (NVCR) shares for $71,568 on Mar 4, 2026

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Mukund Paravasthu sold 5,377 NovoCure Ltd (NVCR) shares for $71,568 on Mar 4, 2026
Date Insider Transaction Shares Price Value Filing
Mar 4, 2026 Mukund Paravasthu S Open-market sale 5,377 held after: 116,078 $13.31 $71,568 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 18 most recent rows are grouped into 17 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. NovoCure Ltd NVCR S Open-market sale 43,246 shares $595.5K at $13.77 SEC filing ↗
  2. NovoCure Ltd NVCR S Open-market sale 5,377 shares $71.6K at $13.31 SEC filing ↗
  3. NovoCure Ltd NVCR A Grant or awardnot a buy/sell decisionreported at zero 45,112 shares $0 at $0.00 SEC filing ↗
  4. NovoCure Ltd NVCR S Open-market sale 408 shares $5.5K at $13.49 SEC filing ↗
  5. NovoCure Ltd NVCR S Open-market sale 1,555 shares $21.2K at $13.66 SEC filing ↗
  6. NovoCure Ltd NVCR F Shares withheld for taxesnot a buy/sell decision 2,133 shares $30.6K at $14.35 SEC filing ↗
  7. NovoCure Ltd NVCR F Shares withheld for taxesnot a buy/sell decision 2,949 shares $36.1K at $12.23 SEC filing ↗
  8. NovoCure Ltd NVCR F Shares withheld for taxesnot a buy/sell decision 168 shares $2.2K at $12.81 SEC filing ↗
  9. NovoCure Ltd NVCR S Open-market sale 592 shares $10.6K at $17.91 SEC filing ↗
  10. NovoCure Ltd NVCR A Grant or awardnot a buy/sell decision 54,975 shares $1,000.0K at $18.19 SEC filing ↗
  11. NovoCure Ltd NVCR S Open-market sale 250 shares $4.6K at $18.54 SEC filing ↗
  12. NovoCure Ltd NVCR S Open-market sale 368 shares $6.7K at $18.28 SEC filing ↗
  13. NovoCure Ltd NVCR S Open-market sale × 2 1,646 shares $33.0K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    267 $20.55 $5.5K SEC filing ↗
    1,379 $19.92 $27.5K SEC filing ↗
  14. NovoCure Ltd NVCR S Open-market sale 2,160 shares $57.9K at $26.81 SEC filing ↗
  15. NovoCure Ltd NVCR A Grant or awardnot a buy/sell decisionreported at zero 30,138 shares $0 at $0.00 SEC filing ↗
  16. NovoCure Ltd NVCR S Open-market sale 44 shares $734 at $16.69 SEC filing ↗
  17. NovoCure Ltd NVCR S Open-market sale 160 shares $2.5K at $15.88 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
NovoCure Ltd NVCR Ordinary Shares 72,832 $17.94 $1.3M 4 EDGAR ↗
NovoCure Ltd — Restricted Share Units 15,337 — — 3 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Mukund Paravasthu reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.